Literature DB >> 17188833

The intrinsic flexibility of IgE and its role in binding FcepsilonRI.

Naomi E Harwood1, James M McDonnell.   

Abstract

The interaction between IgE and its high affinity cellular receptor (FcepsilonRI) is an essential step in the development of allergic responses. Studies have identified the third constant domain of IgE (Cepsilon3) as the receptor binding region. The Cepsilon3 domain has unusual structural features; it was found to be a 'molten globule' structure in an isolated form, only assuming a well structured form upon binding to FcepsilonRI. The conformational flexibility intrinsic to the receptor binding portion of the molecule may be useful to IgE in allowing the large allosteric changes postulated to be required for FcepsilonRI engagement. If allosteric inhibitors can be developed then the dynamic properties of the Cepsilon3 domain may provide opportunities for therapeutic intervention in allergic disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188833     DOI: 10.1016/j.biopha.2006.11.004

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

Review 1.  IgE-dependent signaling as a therapeutic target for allergies.

Authors:  Donald W MacGlashan
Journal:  Trends Pharmacol Sci       Date:  2012-06-30       Impact factor: 14.819

2.  Attenuation of IgE affinity for FcepsilonRI radically reduces the allergic response in vitro and in vivo.

Authors:  James Hunt; Marguerite G Bracher; Jianguo Shi; Sébastien Fleury; David Dombrowicz; Hannah J Gould; Brian J Sutton; Andrew J Beavil
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

3.  Thermal sensitivity and flexibility of the Cε3 domains in immunoglobulin E.

Authors:  Katy A Doré; Anna M Davies; Nyssa Drinkwater; Andrew J Beavil; James M McDonnell; Brian J Sutton
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-08-24       Impact factor: 3.036

Review 4.  IgE Antibodies: From Structure to Function and Clinical Translation.

Authors:  Brian J Sutton; Anna M Davies; Heather J Bax; Sophia N Karagiannis
Journal:  Antibodies (Basel)       Date:  2019-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.